Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. ONON
6. AAPL
7. RTB
8. AZN
9. SPCX
10. FFAI

Go back to Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
(NASDAQ: PRAX) Delayed: 298.95 -11.52 (3.71%)
Previous Close $310.47    52 Week High $ 
Open $312.76    52 Week Low $ 
Day High $314.01    P/E N/A 
Day Low $295.71    EPS $ 
Volume 829,853